Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R B Kammer

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Reviews of Infectious Diseases|November 1, 1982
Moxalactam: clinical summary of efficacy and safetyR B Kammer
Diagnostic Microbiology and Infectious Disease|January 1, 1991
Randomized comparative study of ceftibuten versus cefaclor in the treatment of acute lower respiratory tract infectionsR B Kammer, R Ress
Postgraduate Medical Journal|January 1, 1979
Cefaclor--summary of clinical experienceR B Kammer, L J Short
Infection|January 1, 1979
Cefaclor: summary of clinical experienceR B Kammer, L J Short
Antimicrobial Agents and Chemotherapy|July 1, 1975
Rapid detection of ampicillin-resistant Haemophilus influenzae and their susceptibility to sixteen antibioticsR B Kammer, D A Preston, J R Turner, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 1, 1992
Evaluation of new anti-infective drugs for the treatment of respiratory tract infections. Infectious Diseases Society of America and the Food and Drug AdministrationA W Chow, C B Hall, J O Klein, et al.
American Journal of Clinical Pathology|November 1, 1979
In-vitro activities of cefamandole and cephalothin against 1,881 clinical isolates. A multi-center studyA L Barry, F D Schoenknect, S Shadomy, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1979
Interpretive criteria for cefamandole and cephalothin disk diffusion susceptibility testsA L Barry, F D Schoenknecht, S Shadomy, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Reviews of Infectious Diseases|November 1, 1982
Moxalactam: clinical summary of efficacy and safetyR B Kammer
Diagnostic Microbiology and Infectious Disease|January 1, 1991
Randomized comparative study of ceftibuten versus cefaclor in the treatment of acute lower respiratory tract infectionsR B Kammer, R Ress
Postgraduate Medical Journal|January 1, 1979
Cefaclor--summary of clinical experienceR B Kammer, L J Short
Infection|January 1, 1979
Cefaclor: summary of clinical experienceR B Kammer, L J Short
Antimicrobial Agents and Chemotherapy|July 1, 1975
Rapid detection of ampicillin-resistant Haemophilus influenzae and their susceptibility to sixteen antibioticsR B Kammer, D A Preston, J R Turner, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 1, 1992
Evaluation of new anti-infective drugs for the treatment of respiratory tract infections. Infectious Diseases Society of America and the Food and Drug AdministrationA W Chow, C B Hall, J O Klein, et al.
American Journal of Clinical Pathology|November 1, 1979
In-vitro activities of cefamandole and cephalothin against 1,881 clinical isolates. A multi-center studyA L Barry, F D Schoenknect, S Shadomy, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1979
Interpretive criteria for cefamandole and cephalothin disk diffusion susceptibility testsA L Barry, F D Schoenknecht, S Shadomy, et al.
Pageof 1